From: Relation between GSTP1 polymorphism and oxidative stress in patients with hepatocellular carcinoma
Group | p value | OR | 95% CI for OR | ||||
---|---|---|---|---|---|---|---|
Control (80) | Cases (99) | ||||||
GSTP1 | AA | N (%) | 60 (75) | 45 (45.5) | < 0.001 | ||
GA | N (%) | 20 (25) | 44 (44.4) | ||||
GG | N (%) | 0 (0.0) | 10 (10.1) | ||||
Recessive model (GSTP1) | AA | N (%) | 60 (75) | 45 (45.5) | < 0.001 | 3.6 | Lower, 1.894 |
Upper, 6.843 | |||||||
GA&GG | N (%) | 20 (25) | 54 (54.4) | ||||
Dominant model (GSTP1) | AA&AG | N (%) | 80 (100) | 89 (89.9) | 0.003 | ||
GG | N (%) | 0 (0) | 10 (10.1) | ||||
GSTP1 (mutant versus wild) | Mutant | N (%) | 20 (25.0) | 54 (54.5) | < 0.001* | ||
Wild | N (%) | 60 (75) | 45 (45.5) |